0001646343-19-000006.txt : 20190515
0001646343-19-000006.hdr.sgml : 20190515
20190515160641
ACCESSION NUMBER: 0001646343-19-000006
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190331
FILED AS OF DATE: 20190515
DATE AS OF CHANGE: 20190515
EFFECTIVENESS DATE: 20190515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP
CENTRAL INDEX KEY: 0001646343
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17280
FILM NUMBER: 19828051
BUSINESS ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 201-2
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 213-7033
MAIL ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 201-2
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001646343
XXXXXXXX
03-31-2019
03-31-2019
NEXTHERA CAPITAL LP
900 THIRD AVENUE
SUITE 201-2
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-17280
N
Daniel Malek
Managing Member/CEO
6462137030
Daniel Malek
New York
NY
05-15-2019
0
24
82402
false
INFORMATION TABLE
2
nexthera13f_q12019.xml
Acorda Therapeutics Inc
COM
00484M106
2057
154806
SH
SOLE
154806
0
0
Allergan PLC
SHS
G0177J108
2006
13700
SH
SOLE
13700
0
0
Amarin Corp PLC
SPONS ADR NEW
023111206
3087
148695
SH
SOLE
148695
0
0
Bausch Health Cos Inc
COM
071734107
5080
205660
SH
SOLE
205660
0
0
BioMarin Pharmaceutical Inc
COM
09061G101
733
8250
SH
SOLE
8250
0
0
Audentes Therapeutics Inc
COM
05070R104
9779
250620
SH
SOLE
250620
0
0
Cymabay Therapeutics Inc
COM
23257D103
2792
210257
SH
SOLE
210257
0
0
Chiasma Inc
COM
16706W102
1061
203948
SH
SOLE
203948
0
0
Deciphera Pharmaceuticals Inc
COM
24344T101
995
42865
SH
SOLE
42865
0
0
Exelixis Inc
COM
30161Q104
2150
90356
SH
SOLE
90356
0
0
Global Blood Therapeutics Inc
COM
37890U108
4610
87099
SH
SOLE
87099
0
0
Heron Therapeutics Inc
COM
427746102
9498
388623
SH
SOLE
388623
0
0
Intercept Pharmaceuticals Inc
COM
45845P108
1337
11952
SH
SOLE
11952
0
0
Immunomedics Inc
COM
452907108
6430
334724
SH
SOLE
334724
0
0
Insmed Inc
COM PAR $.01
457669307
8264
284263
SH
SOLE
284263
0
0
Kiniksa Pharmaceuticals Ltd
COM CL A
G5269C101
1223
67692
SH
SOLE
67692
0
0
Madrigal Pharmaceuticals Inc
COM
558868105
432
3452
SH
SOLE
3452
0
0
Neurocrine Biosciences Inc
COM
64125C109
2118
24040
SH
SOLE
24040
0
0
Novartis AG
SPONSORED ADR
66987V109
3834
45329
SH
SOLE
45329
0
0
uniQure NV
SHS
N90064101
2314
38800
SH
SOLE
38800
0
0
Sage Therapeutics Inc
COM
78667J108
986
6200
SH
SOLE
6200
0
0
Sarepta Therapeutics Inc
COM
803607100
2535
21270
SH
SOLE
21270
0
0
Stemline Therapeutics Inc
COM
85858C107
4183
325526
SH
SOLE
325526
0
0
UroGen Pharma Ltd
COM
M96088105
4898
132589
SH
SOLE
132589
0
0